BioTools Innovator
Nonprofit accelerator; no application fee and funding is non-dilutive · Global · Checking status
BioTools Innovator selected 30 companies from nearly 550 applicants for its four-month 2026 virtual accelerator. Participants receive personalized industry mentorship and compete for $300,000 in non-dilutive funding; 2027 applications are not yet open.
Tier 2 · ranked #40biotechequity-freecompetition
ApplyOfficial siteOpen in the live directory
Program intake
We are checking the program's authoritative source for the current application status.
Key facts
| Check size | 2026 cohort competes for $300,000 in non-dilutive funding |
| Terms | Nonprofit accelerator; no application fee and funding is non-dilutive |
| Stage | life-science tools and molecular diagnostics |
| Applications | Checking status |
| Program dates | 2026 closed; 2027 waitlist opens in October |
| Location | Global |
| Remote friendly | Yes |
| Warm intro needed | No — open application |
| Sectors | bio, diagnostics |
| Status | closed |
Always confirm on the official page before applying — dates and terms change.
Background
BioTools Innovator selected 30 companies from nearly 550 applicants for its four-month 2026 virtual accelerator. Participants receive personalized industry mentorship and compete for $300,000 in non-dilutive funding; 2027 applications are not yet open.
How the application really works
The 2026 intake is closed. Join the waitlist for the 2027 application opening in October; applications are reviewed through the MedTech Innovator account.
Tips
- Read the cited current official page before applying because program dates and terms are volatile.
- State fit with the documented stage, geography, and attendance model; do not rely on an aggregator's old terms.
- Ask for the complete investment, fee, and follow-on documents when the public page does not publish them.
Watch out for
- No application fee. The 2026 cohort competes for $300,000 in non-dilutive funding; no participant is guaranteed a cash award.
- The 2026 cohort is closed. The latest cohort announcement states $300,000 in funding, superseding the older $250,000 wording still visible on some program copy.
Track record
- The 2026 cohort of 30 was selected from nearly 550 applicants with input from more than 240 industry judges.
Official 2026 selection was approximately the top 5%: 30 from nearly 550 applications.
Frequently asked questions
- Is this program currently accepting applications?
- The 2026 intake is closed. Join the waitlist for the 2027 application opening in October; applications are reviewed through the MedTech Innovator account.
- What are the current economics?
- No application fee. The 2026 cohort competes for $300,000 in non-dilutive funding; no participant is guaranteed a cash award.
- How large and long is the program?
- 30 companies in 2026; nearly 550 applications and 240+ judges. Four-month virtual mentorship accelerator, summit, workshops, networking, investor/manufacturer/provider pitching, and capstone competition.
- Can founders participate remotely?
- Accelerator is virtual, with in-person summit and capstone opportunities in the US.
- What happens after the program?
- Industry partnerships, visibility, alumni network, and fundraising connections continue; no automatic follow-on check.
Related accelerators
Sources
- biotoolsinnovator.org/apply — Official closed state, waitlist, eligibility, fee, and application route (checked 2026-08-10)
- biotoolsinnovator.org/program — Official program schedule and four-month virtual format (checked 2026-08-10)
- biotoolsinnovator.org/biotools-innovator-2026-cohort-includes-top-30-life-sciences-tools-and-diagnostics-companies — Official 2026 cohort, applicants, judges, and current prize pool (checked 2026-08-10)